HTRS2023.P2.2 Mim8 clinical development program: an overview of FRONTIER studies with results from a multiple ascending dose study of Mim8 in patients with severe hemophilia A with or without factor VIII inhibitors

Abstract

Open access

Peer reviewed

Steven Lentz, Stephanie Seremitis, Anne Louise Nielsen, Jerzy Windyga and Vlady Ostrow

Research and practice in thrombosis and haemostasis, Vol.7, pp.S22-S23

08/2023

DOI: 10.1016/j.rpth.2023.100227

Files and links (1)

url

https://doi.org/10.1016/j.rpth.2023.100227View

Published (Version of record) Open Access

Title: Subtitle: HTRS2023.P2.2 Mim8 clinical development program: an overview of FRONTIER studies with results from a multiple ascending dose study of Mim8 in patients with severe hemophilia A with or without factor VIII inhibitors
Creators: Steven Lentz
Stephanie Seremitis
Anne Louise Nielsen
Jerzy Windyga
Vlady Ostrow
Resource Type: Abstract
Publication Details: Research and practice in thrombosis and haemostasis, Vol.7, pp.S22-S23
DOI: 10.1016/j.rpth.2023.100227
ISSN: 2475-0379
eISSN: 2475-0379
Language: English
Date published: 08/2023
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984463083402771

102 Record Views